About This Item
Skip To
SMILES string
O=C1c2c(cccc2)C(=O)C(=C1C\C=C(\CCCC(CCCC(CCCC(C)C)C)C)/C)C
InChI
1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+
InChI key
MBWXNTAXLNYFJB-LKUDQCMESA-N
agency
BP, Ph. Eur., USP
reg. compliance
FCC
product line
EMPROVE® ESSENTIAL
form
liquid
potency
>33487 mg/kg LD50, oral (Rat)
bp
140-145 °C/0.0013 hPa
mp
-20 °C
transition temp
flash point >109.9 °C
density
0.97 g/cm3 at 20 °C
application(s)
liquid formulation
pharmaceutical
storage temp.
15-25°C
Quality Level
1 of 4
This Item | P1609000 | BP423 | 95271 |
|---|---|---|---|
| application(s) liquid formulation | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) - |
| agency BP, USP, Ph. Eur. | agency EP | agency - | agency - |
| form liquid | form solid | form viscous liquid (Clear) | form viscous liquid |
| product line EMPROVE® ESSENTIAL | product line - | product line - | product line BioXtra |
| density 0.97 g/cm3 at 20 °C | density 0.984 g/mL at 25 °C (lit.) | density 0.984 g/mL at 25 °C (lit.) | density 0.984 g/mL at 25 °C (lit.) |
| reg. compliance FCC | reg. compliance - | reg. compliance - | reg. compliance - |
Legal Information
Application
General description
used together
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
Related Content
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
